Biotherapeutics
About:
BioTherapeutics Inc. (BTI) is a pre-clinical stage company
Website: http://biotherapeuticsinc.com/
Twitter/X: biotherap
Top Investors: Virginia Venture Partners, Virginia Catalyst
Description:
BioTherapeutics Inc. (BTI) is a pre-clinical stage company developing novel small-molecule drugs to treat inflammation associated with autoimmune related disorders and type 2 diabetes (T2D)
Total Funding Amount:
$800000
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Blacksburg, Virginia, United States
Founded Date:
2008-01-01
Contact Email:
info(AT)biotherapeuticsinc.com
Founders:
Josep Bassaganya-Riera
Number of Employees:
11-50
Last Funding Date:
2017-06-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai